InvestorsHub Logo
Followers 22
Posts 6915
Boards Moderated 0
Alias Born 07/31/2006

Re: None

Friday, 08/05/2016 3:45:51 PM

Friday, August 05, 2016 3:45:51 PM

Post# of 95
West Pharmaceutical Services Inc. (NYSE:WST) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Friday. The brokerage presently has a $91.00 target price on the stock. Zacks Investment Research’s target price would suggest a potential upside of 11.66% from the company’s current price
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent WST News